Circulating Annexin A5 Levels after Atrial Switch for Transposition of the Great Arteries: Relationship with Ventricular Deformation and Geometry

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Lai, Clare T M ^a   Chow, Pak cheong ^a   Wong, Sophia J ^a   Chan, Koon wing ^a   Cheung, Yiu fai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PROPEPTIDE TYPE 3 PROCOLLAGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOXY TERMINAL PROPEPTIDE TYPE 1 PROCOLLAGEN; COLLAGEN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; INTERSTITIAL COLLAGENASE; LIPOCORTIN 5; SOTALOL; SPIRONOLACTONE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BLOOD EXAMINATION; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR PARAMETERS; CARDITIS; CELL METABOLISM; CLINICAL ARTICLE; COHORT ANALYSIS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EARLY DIASTOLE; ECCENTRICITY INDEX; ECHOCARDIOGRAPH; EXTRACELLULAR MATRIX; FEMALE; GLOBAL LONGITUDINAL STRAIN; GLOBAL LONGITUDINAL STRAIN RATE DURING SYSTOLE; GREAT VESSELS TRANSPOSITION; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART ATRIUM SWITCH SURGERY; HEART BLOCK; HEART SURGERY; HEART VENTRICLE; HEART VENTRICLE CONTRACTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LATE DIASTOLE; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PULMONARY VALVE STENOSIS; SINUS NODE DISEASE; SURGICAL APPROACH; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; VENTRICULAR MYOCARDIAL DEFORMATION;

EID: 84871424571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052125     Document Type: Article

References (39)

1. Warnes CA, (2009) Transposition of the great arteries. Circulation 114: 2699-2709.
2. Dos L, Teruel L, Ferreira IJ, Rodriguez-Larrea J, Miro L, et al. (2005) Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart 91: 652-656.
3. Khairy P, Landzberg MJ, Lambert J, O'Donnell CP, (2004) Long-term outcomes after the atrial switch for surgical correction of transposition: a meta-analysis comparing the Mustard and Senning procedures. Cardiol Young 14: 284-292.
4. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, van Domburg R, van Rijen EH, et al. (2004) Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J 25: 1264-1270.
5. Redheuil A, Ladouceur M, Azarine A, Laurence Iserin, Daniel Sidi, et al. (2008) Adverse systemic right ventricular remodeling and ventricular interdependence leading to symptoms in atrial switch patients with transposition of the great vessels can be detected by biventricular geometry, function and mass assessment in CMR. J Cardiovasc Magn Reson (Suppl 1): A195.
6. Chow PC, Liang XC, Cheung YF, (2011) Diastolic ventricular interaction in patients after atrial switch for transposition of the great arteries: A speckle tracking echocardiographic study. Int J Cardiol 152: 28-34.
7. Lubiszewska B, Gosiewska E, Hoffman P, Teresińska A, Rózański J, et al. (2000) Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up. J Am Coll Cardiol 36: 1365-1370.
8. Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely GA, et al. (2005) Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation 111: 2091-2098.
9. Sharma R, Bolger AP, Li W, Davlouros PA, Volk HD, et al. (2003) Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol 92: 188-193.
10. Haudek SB, Taffet GE, Schneider MD, Mann DL, (2007) TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 117: 2692-2701.
11. Fedak PW, Verma S, Weisel RD, Li RK, (2005) Cardiac remodeling and failure: from molecules to man (Part I). Cardiovasc Pathol 14: 1-11.
12. Siwik DA, Chang DL, Colucci WS, (2000) Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86: 1259-1265.
13. Bradham WS, Bozkurt B, Gunasinghe H, Mann D, Spinale FG, (2002) Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res 53: 822-830.
14. Awad AE, Kandalam V, Chakrabarti S, Wang X, Penninger JM, et al. (2010) Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner. Am J Physiol Cell Physiol 298: C679-C692.
15. Boersma HH, Kietselaer BL, Stolk LM, Bennaghmouch A, Hofstra L, et al. (2005) Past, present, and future of annexin A5: From protein discovery to clinical applications. J Nucl Med 46: 2035-2050.
16. Ravassa S, González A, López B, Beaumont J, Querejeta R, et al. (2007) Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction. Eur Heart J 28: 2785-2791.
17. Ravassa S, García-Bolao I, Zudaire A, Macías A, Gavira JJ, et al. (2010) Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5. Cardiovasc Res 88: 304-313.
18. Radauceanu A, Ducki C, Virion JM, Rossignol P, Mallat Z, et al. (2008) Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. J Card Fail 14: 467-474.
19. Rossi A, Cicoira M, Golia G, Zanolla L, Franceschini L, et al. (2004) Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis. Heart 90: 650-654.
20. George J, Patal S, Wexler D, Roth A, Sheps D, et al. (2005) Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure. Am Heart J 150: 484-487.
21. López B, González A, Querejeta R, Larman M, Díez J, (2006) Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. J Am Coll Cardiol 48: 89-96.
22. Schwartzkopff B, Fassbach M, Pelzer B, Brehm M, Strauer BE, (2002) Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy. Eur J Heart Fail 4: 439-434.
23. Chow PC, Liang XC, Cheung EW, Lam WW, Cheung YF, (2008) New two-dimensional global longitudinal strain and strain rate imaging for assessment of systemic right ventricular function. Heart 94: 855-859.
24. Ryan T, Petrovic O, Dillon JC, Feigenbaum H, Conley MJ, et al. (1985) An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol 5: 918-927.
25. Kapadia SR, Yakoob K, Nader S, Thomas JD, Mann DL, et al. (2000) Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol 36: 208-212.
26. Römisch J, Schüler E, Bastian B, Bürger T, Dunkel FG, et al. (1992) Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul Fibrinolysis 3: 11-17.
27. Kaneko N, Matsuda R, Hosoda S, Kajita T, Ohta Y, (1996) Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin Chim Acta 251: 65-80.
28. Matsuda R, Kaneko N, Kikuchi M, Chiwaki F, Toda M, et al. (2003) Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room. Resuscitation 57: 171-177.
29. Hrycek A, Cies?lik P, (2012) Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus. Rheumatol Int 32: 1335-1342.
30. Boyajyan AS, Mkrtchyan GM, Hovhannisyan LP, Hovsepyan TJ, (2010) Increased levels of circulating Annexin A5 in Familial Mediterranean fever. J Inflamm (Lond)7: 55.
31. van Heerde WL, de Groot PG, Reutelingsperger CP, (1995) The complexity of the phospholipid binding protein Annexin V. Thromb Haemost. 73: 172-179.
32. van Tits LJ, van Heerde WL, Landburg PP, Boderie MJ, Muskiet FA, et al. (2009) Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis. Biochem Biophys Res Commun 390: 161-164.
33. Genge BR, Cao X, Wu LN, Buzzi WR, Showman RW, et al. (1992) Establishment of the primary structure of the major lipid-dependent Ca2+ binding proteins of chicken growth plate cartilage matrix vesicles: identity with anchorin CII (annexin V) and annexin II. J Bone Miner Res 7: 807-819.
34. Hammerschmidt S, Kuhn H, Grasenack T, Gessner C, Wirtz H, (2004) Apoptosis and necrosis induced by cyclic mechanical stretching in alveolar type II cells. Am J Respir Cell Mol Biol 30: 396-402.
35. Campian ME, Verberne HJ, Hardziyenka M, de Bruin K, Selwaness M, et al. (2009) Serial noninvasive assessment of apoptosis during right ventricular disease progression in rats. J Nucl Med 50: 1371-1377.
36. López B, González A, Díez J, (2010) Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation 121: 1645-1654.
37. Díez J, Laviades C, Mayor G, Gil MJ, Monreal I, (1995) Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 91: 1450-1456.
38. Vohringer M, Mahrholdt H, Yilmaz A, Sechtem U, (2007) Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR). Herz 32: 129-137.
39. Timonen P, Magga J, Risteli J, Punnonen K, Vanninen E, et al. (2008) Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy. Int J Cardiol 124: 293-300.